Director/PDMR Shareholding

RNS Number : 5424C
Dr. Martens PLC
21 June 2021
 

Director/PDMR Shareholding

Notification of Transactions by Directors/Persons Discharging Managerial Responsibility

Dr. Martens plc (the 'Company') announces that on 21 June 2021 the following transaction(s) in the Company's ordinary shares were undertaken by directors / persons discharging managerial responsibility ('PDMRs').

The notification(s) set out below are provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Robyn Perriss

2

Reason for the notification

a)

Position/status

PDMR (Independent Non-Executive Director)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Dr. Martens plc

b)

LEI

213800QPT8YM6NQZPH28

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of GBP 0.01

 

ISIN: GB00BL6NGV24

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£4.1982

20,000 shares

 

d)

Aggregated information

Aggregated Volume

Price

 

 

20,000 shares

£4.1982

 

e)

Date of the transaction

21 June 2021

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUAOKRANUNURR

Companies

Dr. Martens (DOCS)
UK 100

Latest directors dealings